Thioacetamide

Thioacetamide has been used since the 1940s in analytical chemistry as a hydrogen sulfide substitute for precipitating metal sulfides in qualitative analysis [1]. Its ability to hydrolyze in hot aqueous solution to release H₂S in situ made it useful in the separation of metal cations. Toxicologists recognized in the 1950s that thioacetamide caused rapidly progressive hepatic necrosis and cirrhosis in rats, and it became a standard model for experimental liver disease research [2]. This selectivity for the liver made it a valuable research tool for studying liver fibrosis, cirrhosis, and hepatocarcinogenesis [1]. Industrial production is limited to research chemical supply [2].

Exposure is exclusively from research laboratory use as an analytical reagent or experimental model compound [1]. The general public has no exposure pathway [2].

Thioacetamide is metabolically activated by CYP2E1 to thioacetamide-S-oxide and thioacetamide-S,S-dioxide, which react with cellular proteins in the liver, causing lipid peroxidation and centrolobular hepatic necrosis [1]. Chronic exposure causes progressive hepatic fibrosis and cirrhosis. After sustained exposure, hepatocellular carcinomas and cholangiocarcinomas develop — IARC Group 2B and EPA Group B2 classification [2]. Acutely, it also causes thymic atrophy and immunosuppression [1].

Research laboratory chemists and toxicologists [1].

1. Handle thioacetamide in a certified fume hood — it generates H₂S upon hydrolysis [1]. 2. Wear impermeable gloves and eye protection [2]. 3. Dispose as hazardous chemical waste [1].